ProPharma Group, Inc. announces the opening of a new office in Southern California

April 11, 2012

Overland Park, Kansas – Carlsbad, California ProPharma Group is pleased to announce the opening of a new office in Carlsbad, California. This is another significant step for ProPharma Group and its' clients located in Southern California.  This office will provide ProPharma Group’s clients with expanded, streamlined access to an array of services designed to provide continuous compliance throughout the Pharmaceutical, Biotechnology and Medical Device industries.

This is ProPharma Group’s eighth office within the United States.  ProPharma Group's continued growth can be attributed to the organization holding true to its' core principles of Experience, Integrity and Commitment.

The new office is located at 2173 Salk Avenue, Suite 250, Carlsbad, California 92008, Phone: (760) 870-4417.

TAGS:

December 15, 2020

Mydecine Innovations Group Engages ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...

January 28, 2019

ProPharma Group Announces the Acquisition of The Weinberg Group

Overland Park, KS — ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Washington D.C.-based The Weinberg Group Inc. The Weinberg Group is a leading...

January 28, 2019

ProPharma Group Acquires The Weinberg Group

ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Washington D.C.-based The Weinberg Group Inc. The Weinberg Group is a leading provider of regulatory and...